Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Clinical trial NCT00349206 · COMPLETED

Trial details

NCT number: NCT00349206
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Recurrent Melanoma Stage III Melanoma Stage IV Melanoma

Start date: 2006-04-01
Primary completion: 2012-02-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.